Brand Name | Status | Last Update |
---|---|---|
inflatherm | ANDA | 2022-12-07 |
lefluniclo | unapproved drug other | 2023-03-29 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
rheumatic diseases | — | D012216 | M79.0 |
rheumatoid arthritis | EFO_0000685 | D001172 | M06.9 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | 2 | 5 | 21 | 18 | 13 | 58 |
Psoriatic arthritis | D015535 | EFO_0003778 | L40.5 | 1 | — | 1 | 2 | 2 | 6 |
Juvenile arthritis | D001171 | EFO_1002007 | M08 | — | — | — | 1 | 1 | 2 |
Chronic renal insufficiency | D051436 | — | N18 | — | — | — | 1 | — | 1 |
Iga glomerulonephritis | D005922 | EFO_0004194 | — | — | — | — | 1 | — | 1 |
Immunoglobulin g4-related disease | D000077733 | — | D89.84 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Covid-19 | D000086382 | — | U07.1 | 2 | 1 | 1 | — | 1 | 4 |
Lupus nephritis | D008181 | EFO_0005761 | — | — | 1 | 2 | — | — | 2 |
Central nervous system neoplasms | D016543 | — | — | — | 1 | 1 | — | — | 2 |
Polymyalgia rheumatica | D011111 | EFO_0008518 | M35.3 | — | — | 1 | — | — | 1 |
Myasthenia gravis | D009157 | EFO_0004991 | G70.0 | — | — | 1 | — | — | 1 |
Aortic valve stenosis | D001024 | HP_0001650 | — | — | — | 1 | — | — | 1 |
Prostatic neoplasms | D011471 | — | C61 | — | 1 | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Systemic lupus erythematosus | D008180 | HP_0002725 | M32 | 1 | 3 | — | — | 1 | 5 |
Multiple myeloma | D009101 | — | C90.0 | 1 | 2 | — | — | — | 2 |
Melanoma | D008545 | — | — | 1 | 1 | — | — | — | 2 |
Lymphoproliferative disorders | D008232 | Orphanet_2442 | D47.9 | — | 1 | — | — | — | 1 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | 1 | — | — | — | 1 |
Triple negative breast neoplasms | D064726 | — | — | 1 | 1 | — | — | — | 1 |
Breast diseases | D001941 | — | N60-N65 | 1 | 1 | — | — | — | 1 |
Iga vasculitis | D011695 | EFO_1000965 | D69.0 | — | 1 | — | — | — | 1 |
Viremia | D014766 | — | B34.9 | — | 1 | — | — | — | 1 |
Adult-onset still's disease | D016706 | EFO_0007135 | M06.1 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 2 | — | — | — | — | 2 |
Therapeutic equivalency | D013810 | — | — | 1 | — | — | — | — | 1 |
Hiv infections | D015658 | EFO_0000764 | B20 | 1 | — | — | — | — | 1 |
Sarcoma | D012509 | — | — | 1 | — | — | — | — | 1 |
Glioma | D005910 | EFO_0000520 | — | 1 | — | — | — | — | 1 |
Neoplasms | D009369 | — | C80 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Autoimmune diseases | D001327 | HP_0002960 | M30-M36 | — | — | — | — | 4 | 4 |
Herpesviridae infections | D006566 | EFO_0007309 | B00.4 | — | — | — | — | 2 | 2 |
Takayasu arteritis | D013625 | EFO_1001857 | M31.4 | — | — | — | — | 2 | 2 |
Anti-neutrophil cytoplasmic antibody-associated vasculitis | D056648 | — | I77.82 | — | — | — | — | 1 | 1 |
Pregnancy rate | D018873 | — | — | — | — | — | — | 1 | 1 |
Defense mechanisms | D003674 | — | — | — | — | — | — | 1 | 1 |
Treatment refusal | D016312 | — | — | — | — | — | — | 1 | 1 |
Systemic scleroderma | D012595 | EFO_0000717 | M34 | — | — | — | — | 1 | 1 |
Arthritis | D001168 | HP_0001369 | M05-M14 | — | — | — | — | 1 | 1 |
Nephritis | D009393 | — | N05 | — | — | — | — | 1 | 1 |
Drug common name | Leflunomide |
INN | leflunomide |
Description | Leflunomide is a monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide. It has a role as a non-steroidal anti-inflammatory drug, an antineoplastic agent, an antiparasitic agent, an EC 1.3.98.1 [dihydroorotate oxidase (fumarate)] inhibitor, a hepatotoxic agent, a prodrug, a pyrimidine synthesis inhibitor, an immunosuppressive agent, an EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor and a tyrosine kinase inhibitor. It is a monocarboxylic acid amide, a member of isoxazoles and a member of (trifluoromethyl)benzenes. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1 |
PDB | — |
CAS-ID | 75706-12-6 |
RxCUI | — |
ChEMBL ID | CHEMBL960 |
ChEBI ID | 6402 |
PubChem CID | 3899 |
DrugBank | DB01097 |
UNII ID | G162GK9U4W (ChemIDplus, GSRS) |